Cargando…

Switch telomerase to ALT mechanism by inducing telomeric DNA damages and dysfunction of ATRX and DAXX

Activation of telomerase or alternative lengthening of telomeres (ALT) is necessary for tumours to escape from dysfunctional telomere-mediated senescence. Anti-telomerase drugs might be effective in suppressing tumour growth in approximately 85–90% of telomerase-positive cancer cells. However, there...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hu, Yang, Shi, Guang, Zhang, Laichen, Li, Feng, Jiang, Yuanling, Jiang, Shuai, Ma, Wenbin, Zhao, Yong, Songyang, Zhou, Huang, Junjiu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5006076/ https://www.ncbi.nlm.nih.gov/pubmed/27578458 http://dx.doi.org/10.1038/srep32280

Ejemplares similares

ATRX/DAXX: Guarding the Genome against the Hazards of ALT
por: Clatterbuck Soper, Sarah F., et al.
Publicado: (2023)

Alternative lengthening of telomeres is not synonymous with mutations in ATRX/DAXX
por: de Nonneville, Alexandre, et al.
Publicado: (2021)

A critical role of telomere chromatin compaction in ALT tumor cell growth
por: Shi, Guang, et al.
Publicado: (2020)

Colorectal cancer patient-derived organoids and cell lines harboring ATRX and/or DAXX mutations lack Alternative Lengthening of Telomeres (ALT)
por: Falcinelli, Marta, et al.
Publicado: (2023)

Targeting Telomerase and ATRX/DAXX Inducing Tumor Senescence and Apoptosis in the Malignant Glioma
por: Fan, Hueng-Chuen, et al.
Publicado: (2019)

Formal reply to “Alternative lengthening of telomeres is not synonymous with mutations in ATRX/DAXX”
por: Feuerbach, Lars
Publicado: (2021)

The Role of ATRX in the Alternative Lengthening of Telomeres (ALT) Phenotype
por: Amorim, João P., et al.
Publicado: (2016)

Prognostic value of DAXX/ATRX loss of expression and ALT activation in PanNETs: is it time for clinical implementation?
por: Marinoni, Ilaria
Publicado: (2022)

Structural basis for DAXX interaction with ATRX
por: Wang, Xiaoman, et al.
Publicado: (2017)

DAXX-ATRX regulation of p53 chromatin binding and DNA damage response
por: Gulve, Nitish, et al.
Publicado: (2022)

ATRX affects the repair of telomeric DSBs by promoting cohesion and a DAXX-dependent activity
por: Lovejoy, Courtney A., et al.
Publicado: (2020)

Non-functional pancreatic neuroendocrine tumours: ATRX/DAXX and alternative lengthening of telomeres (ALT) are prognostically independent from ARX/PDX1 expression and tumour size
por: Hackeng, Wenzel M, et al.
Publicado: (2022)

Structural and biochemical characterization of DAXX-ATRX interaction
por: Li, Zhuang, et al.
Publicado: (2017)

TOE1 acts as a 3′ exonuclease for telomerase RNA and regulates telomere maintenance
por: Deng, Tingting, et al.
Publicado: (2019)

Rapid and reversible suppression of ALT by DAXX in osteosarcoma cells
por: Yost, Kathryn E., et al.
Publicado: (2019)

Telomere Length Maintenance in Cancer: At the Crossroad between Telomerase and Alternative Lengthening of Telomeres (ALT)
por: De Vitis, Marco, et al.
Publicado: (2018)

Structural and mechanistic insights into ATRX-dependent and -independent functions of the histone chaperone DAXX
por: Hoelper, Dominik, et al.
Publicado: (2017)

Context matters – Daxx and Atrx are not robust tumor suppressors in the murine endocrine pancreas
por: Sun, Chang, et al.
Publicado: (2022)

DAXX/ATRX and MEN1 genes are strong prognostic markers in pancreatic neuroendocrine tumors
por: Park, Joo Kyung, et al.
Publicado: (2017)

Telomere extension by telomerase and ALT generates variant repeats by mechanistically distinct processes
por: Lee, Michael, et al.
Publicado: (2014)

Human cells lacking coilin and Cajal bodies are proficient in telomerase assembly, trafficking and telomere maintenance
por: Chen, Yanlian, et al.
Publicado: (2015)

New players in heterochromatin silencing: histone variant H3.3 and the ATRX/DAXX chaperone
por: Voon, Hsiao P.J., et al.
Publicado: (2016)

Prognostic Significance of Altered ATRX/DAXX Gene in Pancreatic Neuroendocrine Tumors: A Meta-Analysis
por: Wang, Fei, et al.
Publicado: (2021)

Mir-23a induces telomere dysfunction and cellular senescence by inhibiting TRF2 expression
por: Luo, Zhenhua, et al.
Publicado: (2015)

EBV Tegument Protein BNRF1 Disrupts DAXX-ATRX to Activate Viral Early Gene Transcription
por: Tsai, Kevin, et al.
Publicado: (2011)

Control of human adenovirus type 5 gene expression by cellular Daxx/ATRX chromatin-associated complexes
por: Schreiner, Sabrina, et al.
Publicado: (2013)

The THO complex counteracts TERRA R-loop-mediated telomere fragility in telomerase(+) cells and telomeric recombination in ALT(+) cells
por: Fernandes, Rita Valador, et al.
Publicado: (2023)

ATRX represses alternative lengthening of telomeres
por: Napier, Christine E., et al.
Publicado: (2015)

MiR-185 targets POT1 to induce telomere dysfunction and cellular senescence
por: Li, Tingting, et al.
Publicado: (2020)

ATRX, DAXX or MEN1 mutant pancreatic neuroendocrine tumors are a distinct alpha-cell signature subgroup
por: Chan, Chang S., et al.
Publicado: (2018)

PML protein organizes heterochromatin domains where it regulates histone H3.3 deposition by ATRX/DAXX
por: Delbarre, Erwan, et al.
Publicado: (2017)

Immunohistochemical analyses of the expression profiles of INSM1, ATRX, DAXX and DLL3 in solid papillary carcinomas of the breast
por: Yanai, Hirotsugu, et al.
Publicado: (2022)

Teloxantron inhibits the processivity of telomerase with preferential DNA damage on telomeres
por: Maciejewska, Natalia, et al.
Publicado: (2022)

Mutations inhibiting KDM4B drive ALT activation in ATRX-mutated glioblastomas
por: Udugama, M., et al.
Publicado: (2021)

Loss of ATRX, Genome Instability, and an Altered DNA Damage Response Are Hallmarks of the Alternative Lengthening of Telomeres Pathway
por: Lovejoy, Courtney A., et al.
Publicado: (2012)

Telomere clustering drives ALT
por: Min, Jaewon, et al.
Publicado: (2019)

ATRX loss induces multiple hallmarks of the alternative lengthening of telomeres (ALT) phenotype in human glioma cell lines in a cell line-specific manner
por: Brosnan-Cashman, Jacqueline A., et al.
Publicado: (2018)

Telomere regulation in pluripotent stem cells
por: Huang, Yan, et al.
Publicado: (2014)

Rho GDP‐dissociation inhibitor α is a potential prognostic biomarker and controls telomere regulation in colorectal cancer
por: Huang, Dandan, et al.
Publicado: (2017)

A non-genetic switch triggers alternative telomere lengthening and cellular immortalization in ATRX deficient cells
por: Turkalo, Timothy K., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_tm2eidhfevjgp1aaepd2jmknvg